J&J voluntarily recalls certain OTC products
Johnson & Johnson is recalling a number of products because of reports of an unusual mouldy, musty, or mildew-like odour that has been associated with nausea, stomach pain, vomiting or diarrhea in a small number of cases.
Johnson & Johnson is recalling a number of products because of reports of an unusual mouldy, musty, or mildew-like odour that has been associated with nausea, stomach pain, vomiting or diarrhea in a small number of cases. The recall was initiated voluntarily in consultation with the FDA by McNeil Consumer Healthcare, a division of McNeil-PPC, which is part of Johnson & Johnson, for certain lots of OTC products in the Americas, the United Arab Emirates and Fiji, according to a press statement.
The recalled products include various strengths and dosage forms for Benadryl, Motrin, Rolaids, Simply Sleep, St. Joseph Aspirin and Tylenol. The full product recall list may be found here.
McNeil Consumer Healthcare believes that the reported uncharacteristic smell is caused by the presence of trace amounts of 2,4,6-tribromoanisole (TBA). The company explained that the presence of this impurity can result from the breakdown of a chemical that is sometimes applied to wood used to build wood pallets that transport and store product-packaging materials. “The health effects of this chemical have not been well studied, but no serious events have been documented in the medical literature,” said the J&J release.
In December 2009, McNeil Consumer Healthcare also recalled all lots of Tylenol Arthritis Pain 100 count with Ez-Open Cap related to this issue. “McNeil Consumer Healthcare has now applied broader criteria to identify and remove all product lots that it believes may have the potential to be affected, even if they have not been the subject of consumer complaints,” said J&J in the release. “In addition to the product recall, McNeil Consumer Healthcare is continuing investigation into this issue, and is taking further actions that include ceasing shipment of products produced using materials shipped on these wood pallets and requiring suppliers who ship materials to our plants to discontinue the use of these pallets.”
McNeil Consumer Healthcare says it will continue to closely monitor and evaluate the situation and consult with the FDA. The company advises consumers who purchased product from the lots included in the recall to stop using the product and contact McNeil Consumer Healthcare for instructions on a refund or replacement.
Why is the PDA Pharmaceutical Microbiology Conference the Hottest Ticket in the Industry?
October 10th 2024Get a glimpse of the power and popularity behind the PDA Pharmaceutical Microbiology Conference from two planning committee members, Julia Marre, PhD (Associate Director, Scientific and Regulatory Affairs at Pocket Naloxone Corp) and Dawn Watson (Executive Director, Global Micro Quality and Sterility Assurance at Merck). This candid conversation reveals why this industry event is so influential…and always sold out! The speakers discuss what makes the PDA Pharmaceutical Microbiology Conference so vital to industry professionals, as well as how to become a part of this dynamic professional community.
Navigating Annex 1 for Early Phase Sterile Fill Finish in Clinical Supplies
November 21st 2024Stay compliant with Annex 1 for early phase sterile fill finish processes. Discover how to implement robust contamination control strategies, integrate isolator technology, and conduct integrity testing to meet stringent European Union standards. The guide provides a comprehensive look at key elements such as PUPSIT, critical zone controls, and monitoring and training for aseptic processes.
Your Ultimate Guide for CMC Testing Support for Gene and Cell Therapy
November 21st 2024Explore the complexities of gene and cell therapy development with our comprehensive guide to Chemistry, Manufacturing, and Controls (CMC) testing. Learn how our expertise ensures the safety, potency, and quality of advanced therapies, supporting your journey from product development through regulatory approval.
